Citizens Financial Group Inc. RI bought a new stake in shares of Centene Co. (NYSE:CNC – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,019 shares of the company’s stock, valued at approximately $227,000.
Other hedge funds have also bought and sold shares of the company. Park Place Capital Corp raised its holdings in shares of Centene by 1,190.0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after buying an additional 357 shares during the period. WR Wealth Planners LLC lifted its position in shares of Centene by 41.4% during the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after buying an additional 137 shares during the last quarter. Chris Bulman Inc acquired a new stake in Centene in the second quarter valued at approximately $33,000. Riverview Trust Co boosted its position in shares of Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after purchasing an additional 320 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Centene in the second quarter worth about $36,000. Institutional investors own 93.63% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the stock. Wells Fargo & Company dropped their price objective on shares of Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Sanford C. Bernstein dropped their price target on shares of Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 30th. Robert W. Baird cut their price objective on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a research report on Friday, October 25th. Deutsche Bank Aktiengesellschaft increased their target price on Centene from $82.00 to $87.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, TD Cowen raised their price target on shares of Centene from $80.00 to $89.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, Centene presently has a consensus rating of “Moderate Buy” and a consensus price target of $83.92.
Centene Price Performance
Shares of CNC opened at $60.37 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. The stock has a market cap of $30.48 billion, a PE ratio of 10.48, a P/E/G ratio of 0.83 and a beta of 0.49. The firm has a 50-day simple moving average of $66.68 and a two-hundred day simple moving average of $70.46. Centene Co. has a 1-year low of $57.20 and a 1-year high of $81.42.
Insiders Place Their Bets
In other Centene news, CFO Andrew Lynn Asher acquired 17,200 shares of the stock in a transaction dated Wednesday, November 13th. The stock was acquired at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the purchase, the chief financial officer now owns 486,847 shares in the company, valued at $28,305,284.58. This trade represents a 3.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sarah London acquired 4,117 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were bought at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the transaction, the chief executive officer now directly owns 667,229 shares of the company’s stock, valued at approximately $40,567,523.20. This trade represents a 0.62 % increase in their position. The disclosure for this purchase can be found here. 0.33% of the stock is owned by insiders.
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
See Also
- Five stocks we like better than Centene
- Using the MarketBeat Dividend Yield Calculator
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Following Congress Stock Trades
- MarketBeat Week in Review – 11/18 – 11/22
- The How and Why of Investing in Gold Stocks
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.